Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;18(1):38-54.
doi: 10.2174/1871522218666180608114536.

Therapeutic Apheresis in Metabolic Syndrome

V A Voinov  1
Affiliations

Therapeutic Apheresis in Metabolic Syndrome

V A Voinov. Immunol Endocr Metab Agents Med Chem. 2018 May.

Abstract

Background: The metabolic syndrome unites three pathologies of the person - obesity, arterial hypertension and diabetes. In recent years the progressing of such distribution covering from 2.5% to 3.8% of the population with increase twice each 10-15 years is noted. Even at maintenance of level of sugar at diabetes accumulation of the secondary metabolites breaking small vessels isn't excluded. At the same time many life-endangering complications develop.

Objective: To identify the possibilities of plasmapheresis in the prevention and treatment of complications of metabolic syndrome.

Method: Analysis of the world literature data on complications of metabolic syndrome and methods of their treatment.

Results: At metabolic syndrome the frequency of strokes and myocardial infarctions there is twice more often than in population. For 5-9 years the general life expectancy decreases. Disorders of microcirculation at diabetes lead to a retinopathy with total loss of sight, a nephropathy from the outcome in a renal failure, to polyneuropathy and diabetic foot syndrome with high risk of high level amputations of the lower extremities. At the same time medicamentous therapy is not able to prevent such complications and almost only way of removal of these pathological metabolites is therapeutic apheresis, mainly the plasmapheresis. Data from our own studies confirm the effectiveness of such tactics.

Conclusion: Plasmapheresis has to be applied not only to the correction of already critical conditions, but also to their prevention.

Keywords: Metabolic syndrome; diabetes; diabetic foot; diabetic nephropaty; plasma-pheresis; retinopathy.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Patient D, age of 50 years. Diabetic foot. View of foot before an initiation of treatment.
Fig. (2)
Fig. (2)
After course of plasmapheresis and resection of phalanxes of 1-2-3 fingers only.
See this image and copyright information in PMC

References

    1. Tune J.D., Goodwill A.G., Sassoon D.J., Mather K.J. Cardiovascular consequences of metabolic syndrome. Transl. Res. 2017;183:57–70. - PMC - PubMed
    1. Davis R.M., Wagner E.H., Groves T. Managing chronic disease. BMJ. 1999;318(7191):1090–1091. - PMC - PubMed
    1. Goswami G., Shinkazh N., Davis N. Optimal pharmacologic treatment strategies in obesity and type 2 diabetes. J. Clin. Med. 2014;3(2):595–613. - PMC - PubMed
    1. Clarson C.L., Mahmud F.H., Baker J.E., Clark H.E., McKay W.M., Schauteet V.D., Hill D.J. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine. 2009;36(1):141–146. - PubMed
    1. Goh V.H.H., Hart W.G. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas. 2018;107:33–38. - PubMed

LinkOut - more resources